Primary care provider adherence to an alert for intensification of diabetes blood pressure medications before and after the addition of a “chart closure” hard stop
AbstractObjectiveTo evaluate provider responses to a narrowly targeted “Best Practice Advisory” (BPA) alert for the intensification of blood pressure medications for persons with diabetes before and after implementation of a “chart closure” hard stop, which is non-interruptive but demands an action or dismissal before the chart can be closed.Materials and MethodsWe designed a BPA that fired alerts within an electronic health record (EHR) system during outpatient encounters for patients with diabetes when they had elevated blood pressures and were not on angiotensin receptor blocking medications. The BPA alerts were implemented in eight primary care practices within UCLA Health. We compared data on provider responses to the alerts before and after implementing a “chart closure” hard stop, and we conducted chart reviews to adjudicate each alert’s appropriateness.ResultsProviders responded to alerts more often after the “chart closure” hard stop was implemented (P
Authors: Morita K, Wang D, Baba R, Morimoto H, Song Y, Kanazawa T, Yoshida Y Abstract Although it is known that desert dust exacerbates allergic diseases, how it affects the onset of autoimmune diseases is unclear. No epidemiological investigations or animal experiments have been conducted so far to elucidate the effects of desert dust on autoimmune diseases. Here, we focused on particulate matter, such Asian sand dust (ASD) that has been known to cause adverse health effects in East Asian countries, and conducted animal experiments to examine how ASD influences type 1 diabetes (T1D), an autoimmune disease. An ASD ...
Condition: Bile Acid, Microbiota, Treatment of Diabetes Intervention: Sponsor: Chang Gung Memorial Hospital Not yet recruiting
Conditions: Ketosis; Type 2 Diabetes Interventions: Dietary Supplement: Ketone monoester; Dietary Supplement: Placebo Sponsor: University of British Columbia Recruiting
Condition: Type 2 Diabetes Mellitus Interventions: Drug: Dapagliflozin Pill; Drug: Empagliflozin Pill; Drug: Placebo pill Sponsor: Centro Universitario de Ciencias de la Salud, Mexico Not yet recruiting
Antioxidants&Redox Signaling,Volume 32, Issue 1, Page 60-77, January 1, 2020.
Publication date: Available online 11 December 2019Source: International Journal of Nursing SciencesAuthor(s): Lei Cui, Weixia Chen, Xingxing Yu, Changping JuAbstractPurposePatients undergoing maintenance hemodialysis (MHD) have a higher prevalence of cognitive impairment and inferior cognitive performance than the general population, and those with cognitive impairment are at higher risk of death than those without cognitive impairment. Having diabetes has been associated with an increased risk of cognitive decline in end-stage kidney disease patients treated with peritoneal dialysis or kidney transplant. However, these f...
Conclusions: Compared with placebo, ghrelin agonists are effective and well-tolerated for the treatment of DG. PMID: 31816671 [PubMed - as supplied by publisher]
CONCLUSIONS: This study, in line with previous studies, shows that a diagnosis of T1DM is associated with a decreased risk of schizophrenia. This finding of an inverse association between T1DM and schizophrenia may bring an interesting piece, related to autoimmunity, into the schizophrenia-aetiology puzzle. PMID: 31816222 [PubMed - as supplied by publisher]
Type 2 diabetes requires careful monitoring to reduce the risk of blood sugar spikes, which can lead to a host of health problems. Diet plays an essential role in regulating blood sugar and warding off serious threats and evidence backs regularly drinking a certain a certain tea to keep the condition in check.
Pancreas-kidney transplant extends life expectancy for patients with type 1 diabetes and renal disease more than kidney transplantation alone, according to a study published inDiabetes Care.Healio